Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 15 tweets from 13 users, with an upper bound of 191,830 followers.

MT @UKCochraneCentr: Benefits/harms/preferences must be weighed in managing #bloodclots in cancer patients http://t.co/5nIrbkGVS4

Benefits/harms & preferences must be weighed up in managing blood clots in people with cancer http://t.co/wHokJRf4oX #CochraneEvidence

Benefits/harms & preferences must be weighed up in managing blood clots in people with cancer http://t.co/wHokJRf4oX #CochraneEvidence

Benefits/harms & preferences must be weighed up in managing blood clots in people with cancer http://t.co/wHokJRf4oX #CochraneEvidence

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 11 additional tweets.